Autolus Therapeutics (AUTL) Tops Q1 EPS by 4c

Autolus Therapeutics (NASDAQ: AUTL) reported Q1 EPS of ($0.23), $0.04 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
• Ardent Health revises 2025 non-GAAP figures after SEC staff talks